Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Interest & Investment Income (2020 - 2022)

Nutex Health's Interest & Investment Income history spans 6 years, with the latest figure at $368.0 for Q1 2022.

  • For Q1 2022, Interest & Investment Income rose 222.81% year-over-year to $368.0; the TTM value through Mar 2022 reached $1171.0, up 2.36%, while the annual FY2021 figure was $917.0, 10.97% down from the prior year.
  • Interest & Investment Income for Q1 2022 was $368.0 at Nutex Health, up from $288.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1030.0 in Q4 2020 and bottomed at $114.0 in Q1 2021.
  • The 3-year median for Interest & Investment Income is $279.0 (2021), against an average of $385.83.
  • The largest annual shift saw Interest & Investment Income tumbled 72.04% in 2021 before it skyrocketed 222.81% in 2022.
  • A 3-year view of Interest & Investment Income shows it stood at $1030.0 in 2020, then crashed by 72.04% to $288.0 in 2021, then grew by 27.78% to $368.0 in 2022.
  • Per Business Quant, the three most recent readings for NUTX's Interest & Investment Income are $368.0 (Q1 2022), $288.0 (Q4 2021), and $270.0 (Q3 2021).